ZFAS1 and neoplasm: Zinc Finger NFX1-Type Containing 1 (ZFAS1) can forecast the clinical outcome of patients with different neoplasms including colorectal cancer, gastric cancer, and other types of cancer (Ghafouri-Fard et al. 2021).